News
-
According to Swedish CRO Medicon Valley Inhalation Consortium (MVIC), the organization has entered into a 2-year, €1.6 million contract with a Chinese company to develop an inhaled generic drug for the treatment of asthma and… Read more . . .
-
Discovery Laboratories has hired former AstraZeneca Senior Medical Director Steve Simonson as VP, Clinical Development and former PARI VP and Director of Product Technology Lawrence Weinstein as VP, Medical Device Development, the company said. The… Read more . . .
-
Insmed has presented additional positive results from the open label portion of a Phase 2 trial of Arikayce inhaled liposomal amikacin for the treatment-resistant nontuberculous mycobacterial (NTM) lung infections at the American Thoracic Society annual… Read more . . .
-
Aradigm has announced that the FDA has designated its Pulmaquin inhaled ciprofloxacin for the treatment of P. aeruginosa infections in non-cystic fibrosis bronchiectasis patients as a Qualified Infectious Disease Product (QIDP). QIDP status makes the… Read more . . .
-
Reckitt Benckiser Pharmaceuticals will co-develop a unit-dose naloxone nasal spray for the reversal of opioid overdoses with Kentucky-based AntiOp, the company has announced. The only detail of the deal that was released is that the… Read more . . .
-
Kamada has announced that preliminary results from its Phase 2/3 pivotal trial of its inhaled Alpha-1 Antitrypsin (AAT) therapy showed no difference between inhaled AAT and placebo in “time to first moderate or severe exacerbation,”… Read more . . .
-
As part of an interim management statement, Skyepharma has said that the launch of its Flutiform fluticasone/formoterol MDI in Spain could take place by the end of 2014, triggering a milestone payment of €2.0 million.… Read more . . .
-
Pharmaterials, Reading, UK. The jobholder will be part of the inhalation department and will be responsible for supporting projects related to Pharmaceutical Development and Manufacturing operations. The job holder must be well organized, dynamic and… Read more . . .
-
Apotex says that it launched a generic budesonide nasal spray in the US on May 13, 2014 following the previous day’s approval of the product by the FDA. The new product, with a strength of… Read more . . .
-
At the recent Orlando Inhalation Conference, Bing Li of the FDA’s Division of Bioequivalence in the Office of Generic Drugs (OGD) of the Center for Drug Evaluation and Research (CDER) provided a list of frequently… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
No events are found.